Identification of genetic variants in CFAP221 as a cause of primary ciliary dyskinesia by Bustamante-Marin, X.M. et al.
Identification of Genetic Variants in CFAP221 as a Cause of 
Primary Ciliary Dyskinesia
Ximena M. Bustamante-Marin1,#, Adam Shapiro2,#, Patrick R. Sears1, Wu-Lin Charng3, 
Donald F. Conrad3,4, Margaret W. Leigh5, Michael R. Knowles1, Lawrence E. Ostrowski1,*, 
Maimoona A. Zariwala6,*
1Department of Medicine, Marsico Lung Institute, University of North Carolina, Chapel Hill, North 
Carolina., NC 27599, USA.
2Department of Pediatrics, Division of Pediatric Respiratory Medicine, McGill University Health 
Centre Research Institute, Montreal, Quebec.
3Department of Genetics and Psychiatry, Washington University School of Medicine, St. Louis, 
MO 63110, USA
4Division of Genetics, Oregon National Primate Research Center, Beaverton, OR, 97006, USA
5Department of Pediatrics, Marsico Lung Institute, University of North Carolina, Chapel Hill, North 
Carolina, 27599.
6Department of Pathology and Laboratory Medicine, Marsico Lung Institute University of North 
Carolina, Chapel Hill, NC 27599, USA.
Abstract
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
* Corresponding Author: Lawrence E. Ostrowski, 104 Manning Dr Room 6021, ostro@med.unc.edu, Phone: 919-8437177, 
Maimoona A. Zariwala, 7219 A Marsico Hall, maimoona_zariwala@med.unc.edu, Phone: 919-966-7050, Fax: 919-966-5178.
#Ximena M. Bustamante-Marin and Adam Shapiro are co-first authors.
*Lawrence E. Ostrowski and Maimoona A. Zariwala contributed equally to this research.
Contributors:
XBM and LEO wrote the manuscript and MRK and MAZ contributed to the manuscript. XBM, MRK, MAZ and LEO conceived the 
experiments, and designed strategies. XBM cultured the HNE cells, and performed experiments, and MAZ performed genotyping and 
segregation analysis. XBM, LEO, PS, and MAZ analyzed and interpreted data. AS, MWL, MAZ and MRK, identified the patient and 
performed exome sequencing. DFC and WC performed the whole exome sequencing analysis, AS performed nasal scrape, and PS, 
performed waveform analysis. All authors reviewed the manuscript.
Patient consent: Obtained.










Supplementary information is available at the Journal of Human Genetics’ website.
Conflict of interest
The authors declare no conflicts of interest
HHS Public Access
Author manuscript
J Hum Genet. Author manuscript; available in PMC 2020 April 21.
Published in final edited form as:













Primary ciliary dyskinesia (PCD) is a rare disorder that affects the biogenesis or function of motile 
cilia resulting in chronic airway disease. PCD is genetically and phenotypically heterogeneous, 
with causative mutations identified in over 40 genes; however, the genetic basis of many cases is 
unknown.
Using whole exome sequencing, we identified three affected siblings with clinical symptoms of 
PCD but normal ciliary structure, carrying compound heterozygous loss-of-function variants in 
CFAP221. Computational analysis suggests that these variants are the most damaging alleles 
shared by all three siblings. Nasal epithelial cells from one of the subjects demonstrated slightly 
reduced beat frequency (16.5 Hz vs 17.7 Hz, p=0.16); however, waveform analysis revealed that 
the CFAP221 defective cilia beat in an aberrant circular pattern.
These results show that genetic variants in CFAP221 cause PCD and that CFAP221 should be 
considered a candidate gene in cases where PCD is suspected but cilia structure and beat 
frequency appear normal.
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Introduction
Primary ciliary dyskinesia (PCD) is a rare genetic disease (MIM: 244400), caused by 
genetic lesions that impair the function of the motile cilia that line the airways, thereby 
reducing mucociliary clearance and resulting in chronic respiratory infections. Currently 
there are no specific treatments available for PCD, and early diagnosis is crucial to ensure 
proper disease management and minimize loss of lung function1. Advances in whole exome 
sequencing and analysis have contributed to the identification of PCD-causing mutations in 
>40 genes2. However, the underlying genetic cause is still unknown in ~30% of PCD cases, 
and in subjects with no obvious defects in ciliary structure or beat frequency, establishing a 
firm diagnosis remains challenging.
Material and Methods
Subjects
Individuals included in the study had a clinical diagnosis of PCD confirmed by standard 
clinical diagnostic criteria. For studies of affected individuals and their families, a signed 
and informed consent was obtained from all participants. All protocols involving human 
studies were approved by University of North Carolina Medical School and/or McGill 
University Health Centre Research Institute Institutional Review Boards.
Genetic Analysis
Identification of CFAP221 variants was performed by whole exome sequence analysis using 
the population sampling probability (PSAP) framework as previously described3, as detailed 
in Supplementary Information.
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Airway epithelial cell cultures
Human nasal epithelial (HNE) cells from proband 2-I and controls were obtained as 
previously described4. The nasal cells were expanded as conditionally reprogrammed cells 
(CRC)5 and cultured as previously described6. Human bronchial epithelial (HBE) cells 
were cultured at the air/liquid interphase (ALI) as previously described7. These protocols 
have been approved by the University of North Carolina (UNC) Medical School Institutional 
Review Board.
Reverse transcription polymerase chain reaction (RT-PCR)
Semi-quantitative RT-PCR was performed using standard protocols (Takara Bio USA, Inc.), 
as detailed in Supplementary Information.
Waveform analysis and ciliary beat frequency measurements
To evaluate the waveform and beat direction, high resolution videos of ciliated cells were 
recorded and analyzed as described in Supplementary Information.
Results and Discussion
We identified three French-Canadian siblings from family UNC-1200 (Figure 1A) with 
phenotypes suggestive of PCD (Supplementary Table 1), including neonatal respiratory 
distress, chronic sinus disease, recurrent otitis media, and bronchiectasis in two individuals. 
None of the subjects had situs inversus. Sweat chloride testing and immunology 
investigations were normal in all three siblings. The rate of nasal nitric oxide production 
(nNO) was normal (122, 171, 189 nL/min; cut-off of 77 nL/min8), and examination of 
ciliary axonemes by TEM did not reveal obvious ultrastructural defects (Figure 1B).
We carried out whole exome sequencing in one proband (2-II) and analyzed the resulting 
genotype data using a statistical framework for assessing the significance of variants from 
n=1 cases of rare genetic disease3. This identified compound heterozygous variants in cilia 
and flagella associated protein 221 (CFAP221; [GenBank: NM_001271049.2, Chr.2q14.2] 
previously known as PCDP1) as the most damaging variants in the genome of 2-II and most 
plausible cause of a rare recessive disorder (Table 19, 10 and Figure 1C). Segregation 
analysis confirmed that both variants were present in all three affected siblings and parents 
were carriers for each variant (Supplementary Figure 1). A frameshift variant in exon 22 [c.
2303_2307delTAGAA p.Leu768HisFs*5] is predicted to result in a premature termination 
codon. The other variant (c.2318+1G>A) disrupts a canonical splice donor site in intron 22 
that causes aberrant splicing (Figure 1C)9. RT-PCR analysis of exon 22, using primers 
spanning exon 19–23, of control human nasal epithelial (HNE) cells amplified a 539 base 
pair product (Figure 1C). In HNE cells from subject 2-I we confirmed the five base pair 
deletion (r.2303_2307del) resulting in a premature stop codon (Figure 1C). Analysis of the 
intron 22 splice site variant revealed the in frame deletion of exon 22 (r.2226_2318del).This 
is predicted to result in deletion of 31 amino acid residues (p.Cys743_Arg773del) (Figure 
1C).
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We examined the expression and localization of CFAP221 in normal human bronchial 
epithelial (HBE) cells (Supplementary Figure 2) cultured at an air/liquid interface (ALI)7. 
RT-PCR demonstrated that the expression of CFAP221 increased during ciliated cell 
differentiation (Supplementary Figure 2A). Western blotting and immunofluorescence 
showed that CFAP221 is not expressed in undifferentiated airway cells, and is localized 
primarily to the axoneme in differentiated ciliated cells (Supplementary Figure 2B and 2C).
To investigate the impact of the genetic variants in CFAP221 on ciliary function, a nasal 
biopsy from subject 2-I was expanded as conditionally reprogrammed cells11, cultured at the 
ALI to induce differentiation, and examined for CFAP221 expression (Supplementary 
Figure 3A). The localization of CFAP221 in ciliated cells was evaluated by 
immunofluorescence (Supplementary Figure 3B). In contrast to control cells, cells from the 
PCD subject showed no specific staining. The absence of CFAP221 in ciliated cells from 
subject 2-I probably results from the non-sense mediated decay of aberrant transcripts 
(Figure 1). Immunofluorescent staining for other ciliary proteins, RSPH1 and ERICH3 
showed a similar pattern in the 2-I cells, as compared to control cells (Supplementary Figure 
3C). This result agrees with the observation of normal ciliary ultrastructure by TEM (Figure 
1B).
After differentiation of cells from subject 2-I, we observed vigorous ciliary activity, with a 
beat frequency that was only slightly reduced compared to parallel control cultures (16.5 Hz 
vs 17.7 Hz, p=0.16, Figure 2A). However, waveform analysis in the xy direction (top down) 
revealed that the CFAP221-deficient cilia beat in a slightly circular pattern, compared to the 
linear, back and forth motion of control cilia (Figure 2B, 2C and Supplementary Videos 
1-4). This difference, when measured as the maximum deviation from a linear beat, was 
highly significant (control=0.27 ± 0.06 μm; 2-II=0.92 ± 0.5 μm; p<0.0015, n=24 cilia for 
each group).
In a mouse model, mutation of Pcdp1 was reported to cause symptoms of PCD, including 
mucus accumulation in the nasal cavity, male infertility, and hydrocephalus12. Ciliary 
ultrastructure was reported as normal, however ciliary beat frequency (CBF) was reduced 
approximately 25% in tracheal samples of the mutant mice. In Chlamydomonas flagella, the 
orthologue of CFAP221, (FAP221) has been shown to be a component of the central pair 
projection C1d and to bind calcium13. Further, the absence of the C1d complex results in a 
significant impairment of mobility, including a reduced beat frequency and altered 
waveform. These results suggest that CFAP221 might play an important role in calcium-
mediated regulation of dynein activity. This is an interesting hypothesis to explore in 
deciphering the underlying mechanism by which genetic variants of CFAP221 are a likely 
cause of PCD in humans.
Subjects with genetic variants in CFAP221 exhibited typical symptoms of classical PCD, but 
ciliary axonemes appeared normal by TEM. PCD causing mutations in other genes have also 
been associated with apparently normal ciliary ultrastructure14, including DNAH1115–17 
(MIM:603339) and HYDIN15, 18 (MIM: 610812). A more accurate analysis of the axoneme 
structure of CFAP221 deficient cells could be achievable by cryo-electron microscopy. This 
could confirm a central pair defect, as previously shown in Chlamydomonas13. A central 
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pair defect is consistent with a ciliary beat in a circular motion, similar to the pattern of 
ciliary motion in PCD-subjects carrying genetic variants in RSPH119 (MIM: 609314). In 
addition, the nNO levels were normal in all affected individuals, and the CBF was only 
slightly reduced; thus, it is clear that the diagnosis of PCD remains challenging, and a single 
test cannot be relied upon to detect all cases.
Our results demonstrate for the first time that genetic variants that affect the central pair 
protein CFAP221 cause PCD in humans. Our results suggest that in subjects with normal 
ultrastructure and normal or only slightly reduced CBF, CFAP221 should be considered as a 
candidate gene.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1: CFAP221 variants in PCD subjects.
(A) Segregation analysis of CFAP221 genetic variants found in family UNC-1200 [c.
2303_2307delTAGAA p.Leu768Hiffs*5] and c.2318+1G>A p. splice. Filled symbols 
indicate PCD affected individuals.
(B) Transmission electron micrograph of axonemal cross sections of nasal epithelium from 
proband 2-II showing the central pair (arrowhead) surrounded by nine microtubule doublets. 
Outer dynein arms and inner dynein arms (arrows) project from each doublet normally.
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(C) Genomic organization of CFAP221 and sequencing of transcript variants. (top) 
Schematic representation of the genomic localization of the genetic variants in CFAP221 
found in the PCD subjects. Solid box designates exons, horizontal lines designates introns.
(middle) Schematic showing a wild type transcript region of CFAP221 and its corresponding 
sequencing analysis.
(bottom) Reverse-transcriptase polymerase chain reaction with primers 19F or 22F or 23R 
(see Supplementary Table 3 for primer sequences) showed two major transcripts. Transcript 
1 shows the deletion of 5 bases (highlighted in red box, above), leading to a frame shift of 
the sequence, resulting in a premature stop codon. Transcript 2 shows the in frame deletion 
of exon 22. Schematic of wild type and mutant transcripts and the corresponding 
electropherograms with exact location of the deletions are shown. Primers are designated as 
F (forward) and R (reverse) in their corresponding cDNA locations. Exon-exon junctions are 
shown by the vertical solid lines. Base sequence, amino acid sequence, and codon numbers 
are shown.
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Figure 2: Genetic defects in CFAP221 cause defective ciliary waveform.
(A) The CBF in CFAP221 deficient cells (2-II) was slightly reduced compared to control 
(n=6 cultures from each).
(B and C) Two-dimensional plot representing the patterns of the ciliary beat. The tips of 
eight cilia were traced manually in three ciliated cells from each genotype (n = 24 each). 
Deviation from linearity was measured as the furthest ciliary displacement from the linear 
axis as defined by the end-effective and end-recovery positions.
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